Because STAT1 belongs to a genetic signature predicting lung cancer patient survival [19], effects of SIAH2 on STAT1 and the immunological control of tumorigenesis are possible, i.e. SIAH2 may act as tumor promoter via blocking STAT1. Here, SIAH2 is linked to lung cancer.